Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have been considered untreatable are experiencing long-term remissions. Now, researchers have identified a surprising phenomenon that may explain why many cancers don't respond to these drugs, and hints at new strategies to unleash the immune system against disease.
from Top Health News -- ScienceDaily http://bit.ly/2I0Sxiy
No comments:
Post a Comment